These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 26023178)

  • 41. Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death.
    Kristen AV; Dengler TJ; Hegenbart U; Schonland SO; Goldschmidt H; Sack FU; Voss F; Becker R; Katus HA; Bauer A
    Heart Rhythm; 2008 Feb; 5(2):235-40. PubMed ID: 18242546
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Implantable cardioverter-defibrillators after myocardial infarction.
    Myerburg RJ
    N Engl J Med; 2008 Nov; 359(21):2245-53. PubMed ID: 19020326
    [No Abstract]   [Full Text] [Related]  

  • 43. The appropriate evaluation of the patient at risk for sudden death from ventricular arrhythmias.
    Green MS; Ricci J; Wolfe K
    Can J Cardiol; 2000 Jun; 16 Suppl C():13C-5C. PubMed ID: 10887271
    [No Abstract]   [Full Text] [Related]  

  • 44. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
    Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.
    Rolf S; Haverkamp W; Borggrefe M; Breithardt G; Bocker D
    Europace; 2009 Mar; 11(3):289-96. PubMed ID: 19095687
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Electrophysiology testing for risk stratification of patients with ischaemic cardiomyopathy: a call for action.
    Katritsis DG; Zografos T; Hindricks G
    Europace; 2018 Sep; 20(FI2):f148-f152. PubMed ID: 29236981
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primary prevention implantable cardioverter-defibrillator and opportunities for sudden cardiac death risk assessment in non-ischaemic cardiomyopathy.
    Pathak RK; Sanders P; Deo R
    Eur Heart J; 2018 Aug; 39(31):2859-2866. PubMed ID: 30020440
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Sudden cardiac death in patients with left ventricular dysfunction from ischemic heart disease: role of the implantable defibrillator. Evidence, guidelines and good clinical judgment].
    Serdoz LV; Fabris E; Lutman C; Merlo M; Zecchin M; Sinagra G
    G Ital Cardiol (Rome); 2012 Sep; 13(9):592-601. PubMed ID: 22825344
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Risk stratification and prevention of sudden death in patients with heart failure].
    Villacastín J; Bover R; Castellano NP; Moreno J; Morales R; García-Espinosa A
    Rev Esp Cardiol; 2004 Aug; 57(8):768-82. PubMed ID: 15282066
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myocardial scar characteristics based on cardiac magnetic resonance imaging is associated with ventricular tachyarrhythmia in patients with ischemic cardiomyopathy.
    Demirel F; Adiyaman A; Timmer JR; Dambrink JH; Kok M; Boeve WJ; Elvan A
    Int J Cardiol; 2014 Dec; 177(2):392-9. PubMed ID: 25440471
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis.
    Kron J; Sauer W; Schuller J; Bogun F; Crawford T; Sarsam S; Rosenfeld L; Mitiku TY; Cooper JM; Mehta D; Greenspon AJ; Ortman M; Delurgio DB; Valadri R; Narasimhan C; Swapna N; Singh JP; Danik S; Markowitz SM; Almquist AK; Krahn AD; Wolfe LG; Feinstein S; Ellenbogen KA
    Europace; 2013 Mar; 15(3):347-54. PubMed ID: 23002195
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Risk stratification in non ischemic cardiomyopathy: a case report--Case 5/2010].
    Parade U; Klingel K; Kandolf R; Gawaz M; Schreieck J
    Dtsch Med Wochenschr; 2010 Jun; 135(22):1122. PubMed ID: 20514634
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
    Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
    Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Left ventricular lead location and the risk of ventricular arrhythmias in the MADIT-CRT trial.
    Kutyifa V; Zareba W; McNitt S; Singh J; Hall WJ; Polonsky S; Goldenberg I; Huang DT; Merkely B; Wang PJ; Moss AJ; Klein H
    Eur Heart J; 2013 Jan; 34(3):184-90. PubMed ID: 23053173
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [ICD-implantation--for which patients is its value for primary prevention secure?].
    Fiek M; Reithmann C; Steinbeck G
    Dtsch Med Wochenschr; 2006 Sep; 131(39):2165-8. PubMed ID: 16991035
    [No Abstract]   [Full Text] [Related]  

  • 56. Long-term follow-up and risk assessment of arrhythmogenic right ventricular dysplasia/cardiomyopathy: personal experience from different primary and tertiary centres.
    Peters S
    J Cardiovasc Med (Hagerstown); 2007 Jul; 8(7):521-6. PubMed ID: 17568286
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
    Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ
    Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation.
    Fröhlich GM; Holzmeister J; Hübler M; Hübler S; Wolfrum M; Enseleit F; Seifert B; Hürlimann D; Lehmkuhl HB; Noll G; Steffel J; Falk V; Lüscher TF; Hetzer R; Ruschitzka F
    Heart; 2013 Aug; 99(16):1158-65. PubMed ID: 23813845
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 12-Lead electrocardiogram as a predictor of sudden cardiac death: from epidemiology to clinical practice.
    Eranti A; Aro AL; Kenttä T; Holkeri A; Tikkanen JT; Junttila MJ; Huikuri HV
    Scand Cardiovasc J; 2016; 50(5-6):253-259. PubMed ID: 27454252
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How are patients with atrial fibrillation approached and informed about their risk profile and available therapies in Europe? Results of the European Heart Rhythm Association Survey.
    Potpara TS; Pison L; Larsen TB; Estner H; Madrid A; Blomström-Lundqvist C;
    Europace; 2015 Mar; 17(3):468-72. PubMed ID: 25722478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.